Abpro Holdings, Inc. WarrantABPWW
About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Employees: 6
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
53% more capital invested
Capital invested by funds: $394K [Q3] → $603K (+$210K) [Q4]
7% less funds holding
Funds holding: 29 [Q3] → 27 (-2) [Q4]
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Research analyst outlook
We haven’t received any recent analyst ratings for ABPWW.
Financial journalist opinion
We haven’t received any recent news articles for ABPWW.